Biotech boot camp
US funding agencies are turning to a Silicon Valley entrepreneur to focus fledgling biomedical companies on success — even when that means making a scientific course correction.
Send us a link
US funding agencies are turning to a Silicon Valley entrepreneur to focus fledgling biomedical companies on success — even when that means making a scientific course correction.
Europe's research commissioner Carlos Moedas on funding models, diplomacy and scientific advice.
Ryoji Noyori, long-time president of Japan's RIKEN network of basic-research laboratories, has resigned after a year in which the organization was embroiled in controversy over fraudulent stem-cell papers.
As the world warms and technology improves, researchers and institutions should look at their carbon footprints and question whether they really need to travel to academic conferences.
This month marks the 350th anniversary of arguably the first and longest-running scientific journal, Philosophical Transactions: Giving Some Accompt of the Present Undertakings, Studies, and Labours of the Ingenious in Many Considerable Parts of the World.
Republicans in the US Congress have put the NSF under the microscope, questioning its decisions on individual grants and the purpose of entire fields of study.
Easy-to-use mapping tools give researchers the power to create beautiful visualizations of geographic data.
Europe's ambitious but contentious €1-billion HBP has announced changes to its organization in a response to criticism of its management and scientific trajectory by many high-ranking neuroscientists.
A controversial statistical test has finally met its end, at least in one journal.
The NCI call it the end of an era. Harold Varmus, director of the US NCI and former director of the NIH, announced on 4 March that he will be stepping down from his post at the end of the month.
Not only are scientific articles that have strong coverage in social media likely to be cited more in the future, social media is also the tool that allows us to communicate directly with the general public.
The final act in a long-running saga should bring tighter controls on unproven therapies, both at home and abroad.
Researchers are buzzing about a publication that accepts only 'brief ideas'.
The Institute of Medicine takes a step in the right direction but we should move even faster.
A survey finds that 87% of scientists agree with the statement “Scientists should take an active role in public policy debates about issues related to science and technology.
d[3]ouble-blind review [niWsUluYRUOIzRCEqHYY_nature-header.ed_400x400.png]
How scientists can use Twitter to expand their social contacts and find jobs.
An analysis linking the number of researchers in a lab to productivity spurs online debate.
White House plan would increase research and development funding but faces rough road in Congress.
Amid sanctions and a financial crisis, Dmitry Livanov discusses ongoing reforms to science funding.
Forcing research to fit the mould of high-impact journals weakens it. Hiring decisions should be based on merit, not impact factor.
Researchers on social media discuss the potential impact of making peer review more transparent.
A guide to the popular, free statistics and visualization software that gives scientists control of their own data analysis.
The Horizon 2020 programme threatens to siphon away the best scientists from southern Europe.
How using absolute numbers and journal reputation can yield misleading results.
Data show scores given to grant applications by external reviewers don't correlate with what actually gets funded.
Ten people who mattered this year.
£6 billion (ca. 9 billion CHF) package for science and innovation in the years 2016 to 2021 announced. A review of research councils will ensure 'maximum impact' from investment.
The Open Library of Humanities is now open for submissions.